• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国妇产科医师学会委员会意见:第280号,2002年12月。普通妇产科医生在卵巢癌早期检测中的作用。

ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.

出版信息

Obstet Gynecol. 2002 Dec;100(6):1413-6. doi: 10.1016/s0029-7844(02)02630-3.

DOI:10.1016/s0029-7844(02)02630-3
PMID:12468197
Abstract

The purpose of this Committee Opinion is to define the role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Currently, it appears that the best way to detect early ovarian cancer is for both the patient and her clinician to have a high index of suspicion of the diagnosis in the symptomatic woman. In evaluating symptoms, physicians should perform a physical examination, including a pelvic examination. In premenopausal women with symptoms, a CA 125 measurement has not been shown to be useful in most circumstances. In postmenopausal women with a pelvic mass, a CA 125 measurement may be helpful in predicting a higher likelihood of a malignant tumor than a benign tumor, which may be useful in making consultation or referral decisions or both. A woman with a suspicious or persistent complex adnexal mass requires surgical evaluation by a physician trained to appropriately stage and debulk ovarian cancer. Data suggest that currently available screening tests do not appear to be beneficial for screening low-risk, asymptomatic women. An annual gynecologic examination with an annual pelvic examination is recommended for preventive health care.

摘要

本委员会意见的目的是明确普通妇产科医生在卵巢癌早期检测中的作用。目前,对于有症状的女性,检测早期卵巢癌的最佳方法似乎是患者及其临床医生都对该诊断保持高度怀疑指数。在评估症状时,医生应进行体格检查,包括盆腔检查。对于有症状的绝经前女性,在大多数情况下,CA 125检测并无用处。对于有盆腔肿块的绝经后女性,CA 125检测可能有助于预测恶性肿瘤的可能性高于良性肿瘤,这在做出会诊或转诊决定或两者兼有时可能有用。有可疑或持续性复杂附件包块的女性需要由接受过适当分期和减瘤手术培训的医生进行手术评估。数据表明,目前可用的筛查试验对低风险、无症状女性进行筛查似乎并无益处。建议每年进行妇科检查和盆腔检查以进行预防性医疗保健。

相似文献

1
ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.美国妇产科医师学会委员会意见:第280号,2002年12月。普通妇产科医生在卵巢癌早期检测中的作用。
Obstet Gynecol. 2002 Dec;100(6):1413-6. doi: 10.1016/s0029-7844(02)02630-3.
2
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.全科妇产科医生在卵巢癌早期检测中的作用。
Gynecol Oncol. 2002 Dec;87(3):237-9. doi: 10.1006/gyno.2002.6865.
3
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.全科妇产科医生在卵巢癌早期检测中的作用。
Int J Gynaecol Obstet. 2003 Feb;80(2):235-8. doi: 10.1016/s0020-7292(03)00022-5.
4
Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer.委员会意见 No.477:妇产科医生在早期发现上皮性卵巢癌中的作用。
Obstet Gynecol. 2011 Mar;117(3):742-746. doi: 10.1097/AOG.0b013e31821477db.
5
ACOG Committee Opinion. Number 334, May 2006 (replaces No. 186, September 1997): Role of the obstetrician-gynecologist in the screening and diagnosis of breast masses.美国妇产科医师学会委员会意见。第334号,2006年5月(取代1997年9月第186号):妇产科医生在乳腺肿块筛查与诊断中的作用。
Obstet Gynecol. 2006 May;107(5):1213-4. doi: 10.1097/00006250-200605000-00052.
6
Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.委员会意见 No. 716 概要:妇产科医生在平均风险女性上皮性卵巢癌的早期检测中的作用。
Obstet Gynecol. 2017 Sep;130(3):664-665. doi: 10.1097/AOG.0000000000002289.
7
Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.委员会意见 No.716:妇产科医生在平均风险女性上皮性卵巢癌的早期检测中的作用。
Obstet Gynecol. 2017 Sep;130(3):e146-e149. doi: 10.1097/AOG.0000000000002299.
8
Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.妇科癌症筛查。外阴、阴道、子宫内膜和卵巢肿瘤。
Prim Care. 1992 Sep;19(3):607-20.
9
Screening Pelvic Examinations in Adult Women: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center.成年女性盆腔检查筛查:贝斯以色列女执事医疗中心大查房讨论。
Ann Intern Med. 2015 Oct 6;163(7):537-47. doi: 10.7326/M15-1220.
10
ACOG committee opinion. Number 319, October 2005. The role of obstetrician-gynecologist in the assessment and management of obesity.美国妇产科医师学会委员会意见。第319号,2005年10月。妇产科医生在肥胖评估与管理中的作用。
Obstet Gynecol. 2005 Oct;106(4):895-9. doi: 10.1097/00006250-200510000-00055.

引用本文的文献

1
Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population.利用血清脂质组学结合蛋白质生物标志物和机器学习对有症状人群进行卵巢癌早期检测。
Cancer Res Commun. 2025 Sep 1;5(9):1516-1529. doi: 10.1158/2767-9764.CRC-25-0140.
2
Fertility-sparing surgery upon reproductive and oncologic results in ovarian cancer patients stage I (FIGO): a systematic review.I期(国际妇产科联盟)卵巢癌患者保留生育功能手术对生殖及肿瘤学结局的影响:一项系统评价
Arch Gynecol Obstet. 2025 May 23. doi: 10.1007/s00404-025-08062-y.
3
Robot Assisted Laparoscopic Surgery in Gynaecology: An Evolving Assistive Technology.
机器人辅助腹腔镜手术在妇科中的应用:一种不断发展的辅助技术。
Surg Innov. 2024 Jun;31(3):324-330. doi: 10.1177/15533506241238038. Epub 2024 Mar 6.
4
Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian Cancer in Korean Women.血清脂质组学分析揭示韩国女性卵巢癌的独特特征。
Cancer Epidemiol Biomarkers Prev. 2024 May 1;33(5):681-693. doi: 10.1158/1055-9965.EPI-23-1293.
5
D-dimer, Fibrinogen and Tumor Marker Levels in Patients with benign and Malignant Ovarian Tumors.D-二聚体、纤维蛋白原和肿瘤标志物水平在良性和恶性卵巢肿瘤患者中的变化。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4263-4268. doi: 10.31557/APJCP.2023.24.12.4263.
6
Sertoliform endometrioid carcinoma of the right ovary.右卵巢塞尔托利样子宫内膜样癌
Endocrinol Diabetes Metab Case Rep. 2023 Sep 28;2023(3). doi: 10.1530/EDM-23-0046. Print 2023 Jul 1.
7
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.GD2和GD3神经节苷脂作为上皮性卵巢癌所有分期和亚型的诊断生物标志物。
Front Oncol. 2023 Apr 14;13:1134763. doi: 10.3389/fonc.2023.1134763. eCollection 2023.
8
Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care.患者与医疗服务提供者对卵巢癌手术治疗中获取妇科肿瘤学家服务的障碍的看法。
Womens Health Rep (New Rochelle). 2020 Dec 28;1(1):574-583. doi: 10.1089/whr.2020.0090. eCollection 2020.
9
CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels.CA125-Tn酶联免疫吸附测定法提高了血清CA125水平升高患者术前卵巢癌诊断的特异性。
Ann Transl Med. 2021 May;9(9):788. doi: 10.21037/atm-20-8053.
10
Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses.良性附件包块不同组织病理学亚型的超声特征与卵巢恶性风险算法评分的相关性
Medicine (Baltimore). 2018 Aug;97(31):e11762. doi: 10.1097/MD.0000000000011762.